Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000062

Chief Medical Officer sold 11,366 shares at $15.29 ($173,774)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2025-05-14 Sale 10b5-1 −11,366 $15.29 $173,774 106,669 D
Open-market sales · 11,366 sh · avg $15.29 · $173,774
Loading xslF345X05/wk-form4_1747350094.xml…